Baseret på resultaterne af disse in vitro forsøg og emtricitabins kendte eliminationsveje er potentialet for CYP450- medierede interaktioner mellem emtricitabin og andre lægemidler lavt.
Based on the results of these in vitro experiments and the known elimination pathways of emtricitabine, the potential for CYP450 mediated interactions involving emtricitabine with other medicinal products is low.